If my numbers are right (or close), this stock is a screaming buy!!
No debt as well...Makes the drug(s) in pipeline worth about 25M. NO Brainer, buy!
This drastic discount looks like what SGEN when they did a secondary at 15. I bought today at 13.75. Maybe because they missed the earnings estimate they had to px it at 12. They are in third stage trial with TEVA.